Patents/Assignees

Prelude Corporation

4 patents in portfolio

US12571798utility2026
Cancer Biomarkers and Methods of Use Thereof
0 cites
US12487242utility2025
DCIS Recurrence and Invasive Breast Cancer
0 cites
US11821900utility2023
Method of Selection for Treatment of Subjects at Risk of Invasive Breast Cancer
0 cites
US11543411utility2023
DCIS Recurrence and Invasive Breast Cancer
0 cites